Acquisition

(CIN: L67120GJ1994PLC115132) Member: NSE, BSE, MCX, NCDEX & MSEI Depository Participant with CDSL & NSDL AMFI Registered Mutual Fund Distributor SEBI Registered Research Analyst & Portfolio ManMA aY g20 IN2 e5 D-M rIAA Y 2026 September 15, 2026 To, To, BSE Limited National Stock Exchange of India Limited Scrip Code: 540725 / 976824 / 976825 / 977430 Symbol: SHAREINDIA / 977955/ 978025 / 978077 Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Dilution of shareholding in Subsidiary Company pursuant to non- participation in Rights Issue. Sir/Ma’am, Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing regulations”), we hereby inform you that Silverleaf Securities Research Private Limited (“Silverleaf”), a subsidiary of the Company, has undertaken a Rights Issue of equity shares. The Company, being an existing shareholder of Silverleaf, has not subscribed to the aforesaid Rights Issue. The Rights Issue was undertaken by Silverleaf to meet its capital and business requirements. The Company did not participate in the issue as part of its overall capital allocation and investment strategy, resulting in a consequential dilution in its shareholding. Accordingly, upon allotment of equity shares pursuant to the Rights Issue, the Company's shareholding in Silverleaf has diluted from 73.09% to 64.81% of the paid-up share capital of Silverleaf. The aforesaid dilution has occurred solely on account of the Company's non-participation in the Rights Issue and does not involve any sale, transfer or disposal of shares by the Company. There is no change in control of Silverleaf pursuant to the Rights Issue, and Silverleaf continues to remain a subsidiary of the Company. The allotment pursuant to the Rights Issue was made today, on September 15, 2026, pursuant to which the aforesaid dilution in shareholding occurred. The intimation regarding the allotment and the post-Rights Issue shareholding was received by the Company from Silverleaf today on September 15, 2026 at 04: 22 p.m. The detailed disclosure in terms of Regulation 30 of the Listing Regulations, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure. You are requested to kindly take the above information on your records. Thanking you, Yours faithfully, For Share India Securities Limited Vikas Aggarwal Company Secretary & Compliance Officer M. No. F5512 Annexure The details required under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are as under: Particulars Description Name of the target entity, details in Silverleaf Securities Research Private Limited (“Silverleaf”) brief such as size, turnover etc.; Paid-up Share Capital: Rs. 12,50,00,000 consisting of 1,25,00,000 Equity Shares with a face value of Rs. 10/- (Rupees Ten) each Net worth as on March 31, 2026 – Rs. 1,18,46,765.55/- Turnover (FY 2025-26): During FY 2025–26, Silverleaf continued to focus on establishing its business operations, with revenue-generating activities yet to commence during the year. Whether the acquisition would fall Not Applicable. The Company has not acquired any shares or made any within related party transaction(s) and investment in Silverleaf pursuant to the Rights Issue. This disclosure whether the promoter/ promoter group/ pertains to dilution of the Company's shareholding in Silverleaf from group companies have any interest in 73.09% to 64.81% pursuant to non-participation in the Rights Issue the entity being acquired? If yes, nature undertaken by Silverleaf. of interest and details thereof and whether the same is done at “arm’s length”; Industry to which the entity being Financial Services Industry acquired belongs; Objects and impact of acquisition Not Applicable, as there is no acquisition by the Company. The dilution (including but not limited to, has arisen solely due to the Company's non-participation in the Rights disclosure of reasons for acquisition of Issue of its existing subsidiary. target entity, if its business is outside the main line of business of the listed entity); Brief details of any governmental or Not Applicable regulatory approvals required for the acquisition; Indicative time period for completion Not Applicable. The allotment pursuant to Rights Issue was made by of the acquisition; Silverleaf today, on September 15, 2026, pursuant to which the Company's shareholding was diluted. Consideration - whether cash Not Applicable. The Company has not subscribed to the Rights Issue consideration or share swap or any and, accordingly, no consideration has been paid by the Company other form and details of the same; towards the Rights Issue. Cost of acquisition and/or the price at Not Applicable, as no additional shares were acquired by the Company which the shares are acquired; pursuant to the Rights Issue. Percentage of shareholding / control No additional shares were acquired by the Company. The Company's acquired and / or number of shares existing shareholding in Silverleaf has been diluted from 73.09% to acquired; 64.81 % pursuant to the Rights Issue. There is no change in control and Silverleaf continues to remain a subsidiary of the Company. Brief background about the entity Brief background & line of Business: Main business activities of acquired in terms of products/line of Silverleaf include Stock Broking and Proprietary Trading activities. business acquired, date of incorporation, history of last 3 years Date of Incorporation: July 03, 2024 turnover, country in which the acquired entity has presence and any History of last 3 years turnover of Silverleaf is as follows: other significant information (in brief); Financial Year Turnover (Rupees in Crores) FY 2025-26 Nil FY 2024-25 Nil FY 2023-24 NA, since Company was incorporated on July 03, 2024. Silverleaf has its presence in India.